Through
4/26
Slight alterations in the ETS1 protein level can lead to allergic inflammation.
Kara Maxwell, director of the Men & BRCA Program at the Basser Center, is bridging the knowledge gap about how BRCA mutations affect men.
A new technique based on special cell-penetrating peptides promises advantages over current methods for editing the genomes of primary cells, such as patients’ T cells.
Faculty from the School of Veterinary Medicine and Perelman School of Medicine were honored at the Association for Research in Vision and Ophthalmology meeting in New Orleans.
Penn Medicine research shows this test can detect a build-up of abnormal protein deposits linked to Parkinson’s disease in cerebrospinal fluid.
Kim Tallbear, professor of Native studies at the University of Alberta, delivered the Provost’s lecture on diversity on decolonializing science and technology.
An international team of researchers led by Penn geneticists sequenced the genomes of 180 indigenous Africans. The results shed light on the origin of modern humans, African population history, and local adaptation.
With funding from the National Institutes of Health, Roth plans to explore how people view others who change their racial identity based on results from at-home DNA kits.
The Penn Neurogenetics Therapy Center works to achieve a genetic diagnosis for as many patients as possible, and establish clinical trials using novel gene and molecular therapies.
Neonatal intensive care nurse Kimyatta Frazier found solace in a relationship with a genetic counselor at Penn Medicine who would be instrumental in helping her feel more in control of any future cancer diagnoses.
Kiran Musunuru of the Perelman School of Medicine says that gene editing will be the biggest story of the century.
FULL STORY →
More than 260,000 people have signed up to participate in Penn Medicine BioBank, co-directed by Marilyn Ritchie and Dan Rader, which cross-references DNA with electronic health records to discover genetic variants of medical conditions.
FULL STORY →
Jim Wilson of the Perelman School of Medicine has published two new studies supporting the promise of cutting-edge gene therapy, finding evidence that the genetic treatments can be beneficial for years without raising the risk of cancer.
FULL STORY →
Iain Mathieson of the Perelman School of Medicine says that the Iceman genome was one of the first ancient human genomes ever published.
FULL STORY →
Penn Medicine is noted for spearheading gene therapy for cancer treatment, being the first in the nation to use a gene editing tool to combat cancer in 2019.
FULL STORY →
Gene therapy for a rare form of blindness will be tested at Penn Medicine while gene therapy for a condition that causes skeletal deformities and seizures will be tested at the Children’s Hospital of Philadelphia.
FULL STORY →